Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Colorectal Neoplasms

Free Subscription 25.09.2023 1 Am J Surg 6 Ann Surg Oncol 2 BMC Cancer 1 BMC Gastroenterol 1 Br J Cancer 1 Cancer 1 Cancer Lett 1 Eur J Cancer 3 Eur J Surg Oncol 3 Gastroenterology 1 Gastrointest Endosc 2 Gut 1 Int J Cancer 4 Int J Colorectal Dis 1 J Clin Oncol 1 Oncogene 1 Oncol Rep 1 PLoS Biol 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Surg

1. BEAUHARNAIS CC, Crawford A, Springer JE, Sturrock PR, et al
   Racial disparities in survival of early onset colon cancer (Age<50): A matched NCDB analysis.
   Am J Surg. 2023 Aug 28:S0002-9610(23)00428-2. doi: 10.1016/j.amjsurg.2023.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

2. KARAGKOUNIS G, McIntyre SM, Wang T, Chou JF, et al
   ASO Visual Abstract: Rates and Patterns of Recurrence After Microwave Ablation of Colorectal Liver Metastases: A per-Lesion Analysis of 416 Tumors in the Era of 2.45 GHz Generators.
   Ann Surg Oncol. 2023;30:6579-6580.
   PubMed        
   
   
3. SHIMURA Y, Komatsu S, Minami H, Fukumoto T, et al
   ASO Author Reflections: Can the Total Tumor Volume be an Indicator for Optimal Treatment Strategy in Patients with Colorectal Liver Metastases?
   Ann Surg Oncol. 2023;30:6611-6612.
   PubMed        
   
   
4. SHIMURA Y, Komatsu S, Nagatani Y, Funakoshi Y, et al
   ASO Visual Abstract: The Usefulness of Total Tumor Volume as a Prognostic Factor and in Selecting the Optimal Treatment Strategy of Chemotherapeutic Intervention in Patients with Colorectal Liver Metastases.
   Ann Surg Oncol. 2023;30:6613-6614.
   PubMed        
   
   
5. SHIMURA Y, Komatsu S, Nagatani Y, Funakoshi Y, et al
   The Usefulness of Total Tumor Volume as a Prognostic Factor and in Selecting the Optimal Treatment Strategy of Chemotherapeutic Intervention in Patients with Colorectal Liver Metastases.
   Ann Surg Oncol. 2023;30:6603-6610.
   PubMed         Abstract available
   
   
6. KARAGKOUNIS G, McIntyre SM, Wang T, Chou JF, et al
   Rates and Patterns of Recurrence After Microwave Ablation of Colorectal Liver Metastases: A Per Lesion Analysis of 416 Tumors in the Era of 2.45 GHz Generators.
   Ann Surg Oncol. 2023;30:6571-6578.
   PubMed         Abstract available
   
   
7. PHAM H, Dixon E
   Integration of Next-Generation Sequencing in the Surgical Management of Colorectal Liver Metastasis.
   Ann Surg Oncol. 2023;30:6815-6823.
   PubMed         Abstract available
   
   

   
   BMC Cancer

8. NING J, Liu M, Shen J, Wang D, et al
   Expression signature and prognostic value of CREC gene family in human colorectal cancer.
   BMC Cancer. 2023;23:878.
   PubMed         Abstract available
   
   
9. LI K, Zhao F, Guo Y, Wu Q, et al
   Interaction analysis of high-risk pathological features on adjuvant chemotherapy survival benefit in stage II colon cancer patients: a multi-center, retrospective study.
   BMC Cancer. 2023;23:797.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

10. LV B, Cheng X, Xie Y, Cheng Y, et al
    Predictive value of lesion morphology in rectal cancer based on MRI before surgery.
    BMC Gastroenterol. 2023;23:318.
    PubMed         Abstract available
    
    

    
    Br J Cancer

11. DAY D, Park JJ, Coward J, Markman B, et al
    A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer.
    Br J Cancer. 2023 Sep 20. doi: 10.1038/s41416-023-02431.
    PubMed         Abstract available
    
    

    
    Cancer

12. VAN TUIJL LA, Basten M, Pan KY, Vermeulen R, et al
    Depression, anxiety, and the risk of cancer: An individual participant data meta-analysis.
    Cancer. 2023;129:3287-3299.
    PubMed         Abstract available
    
    

    
    Cancer Lett

13. MORRIS MT, Jain A, Sun B, Kurbatov V, et al
    Multi-omic analysis reveals metabolic pathways that characterize right-sided colon cancer liver metastasis.
    Cancer Lett. 2023 Sep 14:216384. doi: 10.1016/j.canlet.2023.216384.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

14. SHKURTI J, van den Berg K, van Erning FN, Lahaye MJ, et al
    Diagnostic accuracy of CT for local staging of colon cancer: A nationwide study in the Netherlands.
    Eur J Cancer. 2023;193:113314.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

15. SMITH HG, Schlesinger NH, Qvortrup C, Chiranth D, et al
    Variations in the definition and perceived importance of positive resection margins in patients with colorectal cancer - an EYSAC international survey.
    Eur J Surg Oncol. 2023;49:107072.
    PubMed         Abstract available
    
    
16. LIU J, Lee JYT, Bedrikovetski S, Traeger L, et al
    Clinical predictors of rectal cancer response after neo-adjuvant (Chemo)Radiotherapy in Australia and New Zealand: Analysis of the Bi-National Colorectal Cancer Audit (BCCA).
    Eur J Surg Oncol. 2023;49:107070.
    PubMed         Abstract available
    
    
17. FRUHLING P, Stillstrom D, Holmquist F, Nilsson A, et al
    Irreversible electroporation of hepatocellular carcinoma and colorectal cancer liver metastases: A nationwide multicenter study with short- and long-term follow-up.
    Eur J Surg Oncol. 2023;49:107046.
    PubMed         Abstract available
    
    

    
    Gastroenterology

18. WONG CC, Zhai J, Yu J
    Reply to "ALKBH5 in Colorectal Cancer: An insufficiently explored and controversial research area".
    Gastroenterology. 2023 Sep 18:S0016-5085(23)05009.
    PubMed        
    
    
19. ISSAKA RB, Chan AT, Gupta S
    AGA Clinical Practice Update on Risk Stratification for Colorectal Cancer Screening and Post-Polypectomy Surveillance: Expert Review.
    Gastroenterology. 2023 Sep 21:S0016-5085(23)04771.
    PubMed         Abstract available
    
    
20. THOMA OM, Naschberger E, Kubankova M, Larafa I, et al
    p21 prevents the exhaustion of CD4+ T cells within the antitumor immune response against colorectal cancer.
    Gastroenterology. 2023 Sep 19:S0016-5085(23)05008.
    PubMed         Abstract available
    
    

    
    Gastrointest Endosc

21. ALOYSIUS MM, Nikumbh T, Goyal H, Thosani N, et al
    High-risk T1 colorectal cancer requires radical resection.
    Gastrointest Endosc. 2023;98:677-679.
    PubMed        
    
    

    
    Gut

22. TATE DJ, Desomer L, Argenziano ME, Mahajan N, et al
    Treatment of adenoma recurrence after endoscopic mucosal resection.
    Gut. 2023;72:1875-1886.
    PubMed         Abstract available
    
    
23. REES CJ, Hamilton W
    BSG guidelines on faecal immunochemical testing: are they 'FIT' for purpose?
    Gut. 2023;72:1805-1806.
    PubMed        
    
    

    
    Int J Cancer

24. OSTERLUND E, Ristimaki A, Makinen MJ, Kytola S, et al
    Atypical (non-V600E) BRAF mutations in metastatic colorectal cancer in population and real-world cohorts.
    Int J Cancer. 2023 Sep 19. doi: 10.1002/ijc.34733.
    PubMed         Abstract available
    
    

    
    Int J Colorectal Dis

25. OZORAN E, Ozata IH, Uymaz DS, Omarov N, et al
    Multimodal assessment after total neoadjuvant therapy versus standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer accurately predicts complete responders.
    Int J Colorectal Dis. 2023;38:229.
    PubMed         Abstract available
    
    
26. LIAO H, Li T, Liang Y, Liu Y, et al
    The benefits of adjuvant chemotherapy are associated with the kind of neoadjuvant therapy in stage ypI rectal cancer: evidence based on population analysis.
    Int J Colorectal Dis. 2023;38:235.
    PubMed         Abstract available
    
    
27. ZAHID JA, Orhan A, Hadi NA, Ekeloef S, et al
    Myocardial injury and long-term oncological outcomes in patients undergoing surgery for colorectal cancer.
    Int J Colorectal Dis. 2023;38:234.
    PubMed         Abstract available
    
    
28. KAMPMAN SL, Smalbroek BP, Dijksman LM, Smits AB, et al
    Postoperative inflammatory response in colorectal cancer surgery: a meta-analysis.
    Int J Colorectal Dis. 2023;38:233.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

29. IRAJIZAD E, Fahrmann JF, Marsh T, Vykoukal J, et al
    Mortality Benefit of a Blood-Based Biomarker Panel for Lung Cancer on the Basis of the Prostate, Lung, Colorectal, and Ovarian Cohort.
    J Clin Oncol. 2023 Jun 28:JCO2202424. doi: 10.1200/JCO.22.02424.
    PubMed         Abstract available
    
    

    
    Oncogene

30. KASI PM, Hidalgo M, Jafari MD, Yeo H, et al
    Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer.
    Oncogene. 2023 Sep 21. doi: 10.1038/s41388-023-02835.
    PubMed         Abstract available
    
    

    
    Oncol Rep

31. CHEN WS, Zhang X, Zhao ZF, Che XM, et al
    MBNL1?AS1 attenuates tumor cell proliferation by regulating the miR?29c?3p/BVES signal in colorectal cancer.
    Oncol Rep. 2023;50:191.
    PubMed         Abstract available
    
    

    
    PLoS Biol

32. HUBERT CG, Stauffer SR, Lathia JD
    A TOX-ic axis of epigenetic stem cell maintenance and chemoresistance in colon cancer.
    PLoS Biol. 2023;21:e3002295.
    PubMed         Abstract available
    
    

    
    PLoS One

33. YAO D, He W, Hu Y, Yuan Y, et al
    Prevalence and influencing factors of probiotic usage among colorectal cancer patients in China: A national database study.
    PLoS One. 2023;18:e0291864.
    PubMed         Abstract available
    
    
34. SUTTON TS, Hao S, Suzuki M, Chua A, et al
    Rectal cancer presentation during the COVID-19 pandemic: Are decreasing screening rates leading to an increase in acute presentations?
    PLoS One. 2023;18:e0291447.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: